Pineridge Advisors LLC Royalty Pharma PLC Transaction History
Pineridge Advisors LLC
- $265 Billion
- Q4 2024
A detailed history of Pineridge Advisors LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Pineridge Advisors LLC holds 250 shares of RPRX stock, worth $8,355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 172
45.35%
Holding current value
$8,355
Previous $4.86 Million
31.37%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RPRX
# of Institutions
429Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.32 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.25 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$769 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$567 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$472 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...